pimodivir
non‐nucleotide inhibitor of the polymerase basic protein 2 (PB2) subunit of the influenza A that is active against H1N1, H7N9 and H5N1, as well as influenza A strains with reduced susceptibility to NAIs
Also Known As:
(2S,3S)-3-((5-Fluoro-2-(5-fluoro-1H-pyrrolo(2,3-b)pyridin-3-yl)-4-pyrimidinyl)amino)bicyclo(2.2.2)octane-2-carboxylic acid; Bicyclo(2.2.2)octane-2-carboxylic acid, 3-((5-fluoro-2-(5-fluoro-1H-pyrrolo(2,3-b)pyridin-3-yl)-4-pyrimidinyl)amino)-, (2S,3S)-; JNJ-63623872; VX-787
Networked: 16
relevant articles (2 outcomes,
6 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Leopold, Lorant:
3 articles
(12/2022 - 01/2018)
|
2. | Vingerhoets, Johan:
3 articles
(12/2022 - 01/2018)
|
3. | Charifson, Paul S:
3 articles
(02/2017 - 03/2015)
|
4. | Clark, Michael P:
3 articles
(02/2017 - 03/2015)
|
5. | Ledeboer, Mark W:
3 articles
(02/2017 - 03/2015)
|
6. | Leeman, Joshua R:
3 articles
(02/2017 - 03/2015)
|
7. | Perola, Emanuele:
3 articles
(02/2017 - 03/2015)
|
8. | Anderson, David:
2 articles
(12/2022 - 01/2019)
|
9. | Kosoglou, Teddy:
2 articles
(12/2022 - 01/2019)
|
10. | van Duijnhoven, Wilbert:
2 articles
(12/2022 - 01/2019)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures